Page 4 - பைரேந்திரா சராஃப் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பைரேந்திரா சராஃப். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பைரேந்திரா சராஃப் Today - Breaking & Trending Today

Bombay HC dismisses plea to restrict SII's Covishield trademark use


Bombay HC dismisses plea to restrict SII’s Covishield trademark use
Bombay High Court
Mumbai: A division bench of Justices Nitin Jamdar and Chandrakant Bhadang of the Bombay High Court dismissed a plea from a Nanded-based pharmaceutical firm that sought injunction against the Serum Institute of India (SII) from using the name ‘Covishield’ as a trademark.
The bench observed that asking SII to not use Covishield as a trademark would cause confusion in the vaccine administration drive undertaken by the state. The firm, Cutis Biotech, that sells hand sanitisers under the brand name Covishield, claimed to have applied for registration of the trademark for its products. ....

Nitin Jamdar , Chandrakant Bhadang , Birendra Saraf , Purchase Department , Bombay High Court , Serum Institute Of India , Justices Nitin Jamdar , Serum Institute , Cutis Biotech , நிடின் ஜம்தார் , பைரேந்திரா சராஃப் , கொள்முதல் துறை , குண்டு உயர் நீதிமன்றம் , சீரம் நிறுவனம் ஆஃப் இந்தியா , நீதிபதிகள் நிடின் ஜம்தார் , சீரம் நிறுவனம் , குட்டிஸ் பயோடெக் ,

Cutis Biotech claims 'Covishield' over prior use; Bombay HC says 'No', will cause confusion


Cutis Biotech claims Covishield over prior use; Bombay HC says No , will cause confusion
The court order noted that union government had rolled out an extensive vaccination drive and, as on March 16, 66 million doses of Covishield have been supplied to the Centre
Vidya | April 20, 2021 | Updated 23:29 IST
Bombay High Court has refused to restrain Serum Institute of India from using the name Covishield for its vaccine against COVID-19, noting that such an order would create confusion and disruption in the vaccine administration programme.
A division bench of Justices Nitin Jamdar and CV Bhadang dismissed an appeal filed by Nanded-based pharmaceutical firm Cutis Biotech, which sought that Serum Institute should be stopped from using the word as it belonged to them. ....

Nitin Jamdar , Birendra Saraf , Bombay High Court , Serum Institute , Serum Institute Of India , Justices Nitin Jamdar , Cutis Biotech , Bharat Biotech , நிடின் ஜம்தார் , பைரேந்திரா சராஃப் , குண்டு உயர் நீதிமன்றம் , சீரம் நிறுவனம் , சீரம் நிறுவனம் ஆஃப் இந்தியா , நீதிபதிகள் நிடின் ஜம்தார் , குட்டிஸ் பயோடெக் , பாரத் பயோடெக் ,